Abstract Body

Early diagnosis and initiation of treatment in patients with pulmonary TB is a cornerstone TB control and is aimed at reducing morbidity, mortality and duration of infectiousness. WHO guidelines recommend symptom screening for TB disease at all health visits which, if symptoms are present, triggers laboratory investigation, usually of sputum. This is in contrast to HIV testing; where universal testing of adolescents and adults is recommended. Risk or symptoms do not determine who is tested for HIV. The strategy of universal testing for TB irrespective of the presence of symptoms suggestive of TB has been applied to groups at extreme risk for TB. Data from several sources suggest that testing sputum of all people with liquid culture detects several fold the number of cases of TB that symptom-based TB testing would diagnose. However, evidence of improved outcomes of this strategy is limited. Several of these high risk populations, – HIV-infected pregnant women, HIV-infected adults initiating antiretrovirals, household contacts and prisoners will be presented, together with the potential benefits and other implications of universal TB testing strategies.